IM Cannabis Corp. (IMCC) vs Petros Pharmaceuticals, Inc. (PTPI)

IM Cannabis Corp. and Petros Pharmaceuticals, Inc. are both Drug Manufacturers Specialty & Generic companies. IM Cannabis Corp. and Petros Pharmaceuticals, Inc. are of similar size ($1.0M and $980.0K). IM Cannabis Corp. grew revenue faster over the last twelve months: −12.0% against −12.2%. Petros Pharmaceuticals, Inc. has the higher net margin (0.00% vs −38.9%) and the higher return on invested capital (0.00% vs 0.00%). Across the 15 metrics below, Petros Pharmaceuticals, Inc. leads on 8 and IM Cannabis Corp. on 7.

Valuation

Metric IMCC PTPI Drug Manufacturers Specialty & Generic median
P/E n/m n/m 20.55
P/S 0.01 n/m 2.08
P/B n/m n/m 1.79
Price to free cash flow n/m n/m 16.29
EV/EBITDA 0.01 n/m 12.22
EV/Sales 0.00 0.62 2.87
Earnings yield (13,047.81%) 0.00% (15.94%)
Free cash flow yield (267.31%) 0.00% 0.00%

Profitability

Metric IMCC PTPI Drug Manufacturers Specialty & Generic median
Gross margin 12.62% 118.32% 53.51%
Operating margin (32.88%) 0.00% 0.00%
Net margin (38.92%) 0.00% (2.45%)
Free cash flow margin (1.47%) 0.00% 0.00%
Return on equity 2,280.06% (710.28%) (0.80%)
Return on assets (54.20%) (334.15%) (1.67%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric IMCC PTPI Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) (11.97%) (12.20%) 5.22%
EPS growth (last fiscal year) 41.95% 98.13% 42.91%
Revenue growth, 5-year CAGR 26.99% (19.98%) 7.24%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric IMCC PTPI Drug Manufacturers Specialty & Generic median
Debt to equity (0.12) 0.00 0.04
Current ratio 0.56 1.25 2.41
Net debt to EBITDA 0.18 1.11 1.01

Dividend

Metric IMCC PTPI Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.45%
Payout ratio — — 0.27

Size

Metric IMCC PTPI Drug Manufacturers Specialty & Generic median
Market cap 980.00k 1.04m 315.39m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack